Life Lessons presents Dr. Edward Kim, Oncologist. Every September, experts gather for the world’s largest lung cancer conference to share the latest advances in treating a disease that is known to many as a fatal illness. But, in recent years, there have been incredible scientific advancements that have led to new ways of treating the disease – and new hope for patients. A big problem is that people are usually diagnosed in later stages, when the cancer is hard to treat. Here to explain what’s being done to help the roughly 43-thousand Americans diagnosed with Stage 3 non-small cell lung cancer each year and to share some of the latest advances is Dr. Edward Kim, Chair of the Department of Solid Tumor Oncology at the Levine Cancer Institute. What are the challenges surrounding a lung cancer diagnosis and treatment?Some of the most exciting data at the World Conference on Lung Cancer is focused on unresectable Stage 3 non-small cell lung cancer. Can you tell us more about that type of disease?Why are the data in this setting so exciting?What is Immunotherapy?It sounds like early detection can be critical. How would someone know if they might have lung cancer – what are some of the common symptoms?What would you say to patients diagnosed with Stage 3 non-small cell lung cancer? Chair of the Department of Solid Tumor Oncology and Investigational Therapeutics Medical Director, Clinical Trials Office
